1. Takhviji V, Zibara K, Maleki A, et al. A case-control study on factor V Leiden: an independent, gender-dependent risk factor for venous thromboembolism. Thrombosis J. 2021;19:74. https://thrombosisjournal.biomedcentral.com/articles/10.1186/s12959-021-00328-0#citeas. Accessed 1 Feb 2022.
2. Meinardi JR, Middeldorp S, de Kam PJ, Koopman MMW, van Pampus ECM, Hamulyák K, et al. Risk of venous thromboembolism in carriers of factor V Leiden with a concomitant inherited thrombophilic defect: a retrospective analysis. Blood Coagul Fibrinolysis. 2001;12(8):713–20.
3. Albagoush SA, Koya S, Chakraborty RK, et al. Factor V Leiden mutation. In: StatPearls [Internet]. Treasure Island, FL: StatPearls Publishing; 2022. Accessed 1 Feb 2022 [updated 2021 Dec 12].
4. Bloomenthal D, von Dadelszen P, Liston R, Magee L, Tsang P. The effect of factor V Leiden carriage on maternal and fetal health. CMAJ. 2002;167(1):48–54.
5. Kujovich JL. Factor V Leiden Thrombophilia. 1999 May 14. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. GeneReviews® [Internet]. Seattle, WA: University of Washington, Seattle; 1993-2022 [updated 2018 Jan 4]. https://www.ncbi.nlm.nih.gov/books/NBK1368/. Accessed 1 Feb 2022.